Trailing-twelve-month (TTM) revenue is $43.62 Million with a year-over-year growth of (7.12%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-27 | $11,962,425 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-12 |
| Q4 FY2025Period ended 2025-12-27 | $8,367,931 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-13 |
| Q1 FY2026Period ended 2026-03-28 | $10,551,370 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-12 |
| Q2 FY2026Period ended 2026-06-27 | $12,734,434 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-11 |
| TTM revenue | $43,616,160 |
Current P/S: $926,505,000 market capitalization ÷ $43,616,160 TTM revenue = 21.24x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T19:00:06.000Z. Latest revenue period ended 2026-06-27.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-27): $12.73M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:02:18.213Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-27 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-26 · USD | FY20212021-12-25 · USD | FY20222022-12-31 · USD | FY20232023-12-30 · USD | FY20242024-12-28 · USD | FY20252025-12-27 · USD |
|---|---|---|---|---|---|---|
| Collaboration | N/A | N/A | N/A | N/A | N/A | $399,000 |
| Consumer | N/A | $2M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-26 · USD | FY20212021-12-25 · USD | FY20222022-12-31 · USD | FY20232023-12-30 · USD | FY20242024-12-28 · USD | FY20252025-12-27 · USD |
|---|---|---|---|---|---|---|
| Americas | $33M | $32M | $39M | $35M | $48M | $37M |
| Asia Pacific | $6M | $12M | $8M | $4M |
$43.62M
$43.62 Million
(7.12%)
vs. $46.96M a year ago (TTM)
(0.63%)
5 Year compound annual growth rate
1 Year
(7.12%)
3 Year
(2.01%)
5 Year
(0.63%)
10 Year
+6.57%
15 Year
(7.07%)
20 Year
(3.52%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $38.47M | ($11.87M) | (23.58%) |
| 2024 | $50.34M | +$9.94M | +24.61% |
| 2023 | $40.39M | ($7.01M) | (14.78%) |
| 2022 | $47.40M | +$1.74M | +3.80% |
| 2021 | $45.67M | +$5.54M | +13.80% |
| 2020 |
TTM Growth
(7.12%)
3-Year CAGR
(2.01%)
5-Year CAGR
(0.63%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T19:02:18.213Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-27 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $573,000 |
| $25,000 |
| $9,000 |
| Defense | N/A | $18M | $25M | $23M | $41M | $29M |
|---|
| Grant | N/A | N/A | N/A | N/A | N/A | $858,000 |
|---|
| Industrial | N/A | $10M | $6M | $3M | $2M | $3M |
|---|
| License and Royalties | N/A | $1M | N/A | $1M | $442,000 | $410,000 |
|---|
| License And Royalties | N/A | N/A | $624,000 | N/A | N/A | N/A |
|---|
| Medical | N/A | N/A | N/A | N/A | $103,000 | $594,000 |
|---|
| Net Product Revenues | $29M | N/A | N/A | N/A | N/A | N/A |
|---|
| Other | N/A | $121,000 | $7,000 | $13,000 | N/A | N/A |
|---|
| Other Product | N/A | N/A | N/A | N/A | $320,000 | $78,000 |
|---|
| Research and Development | N/A | $15M | N/A | $13M | $6M | $5M |
|---|
| Research And Development | N/A | N/A | $14M | N/A | N/A | N/A |
|---|
| Research and Development and Other Revenues | $12M | N/A | N/A | N/A | N/A | N/A |
|---|
| $1M |
| Europe | $1M | $1M | $1M | $2M | $782,000 | $961,000 |
|---|
| Other Americas | $101,000 | N/A | $4,000 | $5,000 | $5,000 | $62,000 |
|---|
| UNITED STATES | $33M | $32M | $39M | $35M | $48M | $37M |
|---|
| $40.13M |
| +$10.61M |
| +35.94% |
| 2019 | $29.52M | +$5.05M | +20.66% |
| 2018 | $24.47M | ($3.38M) | (12.13%) |
| 2017 | $27.84M | +$5.20M | +22.96% |
| 2016 | $22.64M | ($9.41M) | (29.36%) |
